253 related articles for article (PubMed ID: 13886263)
1. Preparation of typhoid somatic-antigen vaccine. III. The rabbit intracutaneous challenge with Salmonella typhi in mucin.
DIENA BB; WALLACE R; GREENBERG L
Can J Microbiol; 1962 Feb; 8():35-41. PubMed ID: 13886263
[No Abstract] [Full Text] [Related]
2. Preparation of typhoid somatic-antigen vaccine. I. Biological studies of Salmonella typhi lysates.
DIENA BB; WALLACE R; GREENBERG L
Can J Microbiol; 1962 Feb; 8():19-26. PubMed ID: 13886261
[No Abstract] [Full Text] [Related]
3. Preparation of typhoid somatic-antigen vaccine. II. Serological studies of Salmonella typhi lysates.
DIENA BB; WALLACE R; GREENBERG L
Can J Microbiol; 1962 Feb; 8():27-33. PubMed ID: 13886262
[No Abstract] [Full Text] [Related]
4. Mouse challenge with Salmonella typhosa T 5501 in testing the potency of typhoid vaccines.
FISEK NH; GOREN S; AKYAY N
Bull World Health Organ; 1959; 20(6):1257-9. PubMed ID: 13823157
[No Abstract] [Full Text] [Related]
5. Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.
Levin DM; Wong KH; Reynolds HY; Sutton A; Northrup RS
Infect Immun; 1975 Dec; 12(6):1290-4. PubMed ID: 54336
[TBL] [Abstract][Full Text] [Related]
6. [Properdin level and antibody production in the rabbit during immunization with Mycobacterium tuberculosis and Salmonella typhosa].
HEYMANN G; WAHLIG H
Z Immun exp ther; 1959 Jul; 118():57-72. PubMed ID: 14401639
[No Abstract] [Full Text] [Related]
7. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
8. Typhoid vaccine development with a human challenge model.
Feasey NA; Levine MM
Lancet; 2017 Dec; 390(10111):2419-2421. PubMed ID: 28965714
[No Abstract] [Full Text] [Related]
9. A conjugate vaccine against typhoid fever.
Park SE; Marks F
Lancet Infect Dis; 2014 Feb; 14(2):90-1. PubMed ID: 24290842
[No Abstract] [Full Text] [Related]
10. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
11. The immunizing capacity of a five years old dried typhoid vaccine.
Dimache G; Dimache V; Croitoru M
Arch Roum Pathol Exp Microbiol; 1981; 40(1):55-9. PubMed ID: 7185349
[No Abstract] [Full Text] [Related]
12. Studies on the effectiveness of and reactions to adsorbed bacillary typhoid vaccine.
BARSY G; TOLNAI G
Acta Microbiol Acad Sci Hung; 1956; 3(4):373-82. PubMed ID: 13354307
[No Abstract] [Full Text] [Related]
13. A contribution to the laboratory assay of typhoid vaccines.
RASKA K; MATEJOVSKA D; JELINEK J
Bull World Health Organ; 1962; 26(3):381-8. PubMed ID: 14490443
[TBL] [Abstract][Full Text] [Related]
14. [Studies on incomplete antibodies during typhoid immunization. 1. On incomplete antibodies in the blood serum of typhoid bacilli immunized rabbits].
MIZUTANI T
Nihon Saikingaku Zasshi; 1961 May; 16():379-85. PubMed ID: 13771547
[No Abstract] [Full Text] [Related]
15. [Effectiveness of the vaccine of Vi-antigen of Salmonella typhosa in children and adolescents].
D'iachenko PN; Dzhumaliev ND; Koshotov T; Zhoroev Zh
Zdravookhr Kirg; 1975; (5):49-53. PubMed ID: 1943
[No Abstract] [Full Text] [Related]
16. Studies on infection and immunity in experimental typhoid fever. III. Effect of prophylactic immunization.
GAINES S; LANDY M; EDSALL G; MANDEL AD; TRAPANI RJ; BENENSON AS
J Exp Med; 1961 Sep; 114(3):327-42. PubMed ID: 13702952
[TBL] [Abstract][Full Text] [Related]
17. A SUGGESTION FOR A NEW ANTITYPHOID VACCINE.
ANDERSON ES; GUNNELL A
Lancet; 1964 Dec; 2(7371):1196-200. PubMed ID: 14215557
[No Abstract] [Full Text] [Related]
18. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.
Mai NL; Phan VB; Vo AH; Tran CT; Lin FY; Bryla DA; Chu C; Schiloach J; Robbins JB; Schneerson R; Szu SC
N Engl J Med; 2003 Oct; 349(14):1390-1. PubMed ID: 14523155
[No Abstract] [Full Text] [Related]
19. Development of a synthetic Vi polysaccharide vaccine for typhoid fever.
Ni Y; Springer MJ; Guo J; Finger-Baker I; Wilson JP; Cobb RR; Turner D; Tizard I
Vaccine; 2017 Dec; 35(51):7121-7126. PubMed ID: 29150208
[TBL] [Abstract][Full Text] [Related]
20. [Production of a complex chemical typhoid vaccine containing O-, Vi, and H-antigens].
Gekker VD; Sergeeva NS
Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):14-8. PubMed ID: 4780106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
